Current and Future Studies
Participant Feedback
 
 
 
  ACR Utah 801-542-8190
 ACR Idaho 208-377-8653
 
Type 2 Diabetes Clinical Research

Living with diabetes is complicated.

What would you do with FREE time away from some of the daily worries and burden of treating diabetes?

FREEDOM-CVO is a clinical research study investigating an innovative approach to delivering treatment for type 2 diabetes that doesn't require needles or even pills. This study is now enrolling.

You may be able to take part if you:
-have been diagnosed with type 2 diabetes for more than 3 months
-are at least 40 years of age and have been diagnosed with a condition related to your heart or blood vessels, or
-are at least 60 years of age with a risk factor for developing problems with your heart or blood vessels, in addition to your diabetes.

The study of this investigational new drug is expected to last for up to 65 months (5 years and 5 months), and you will receive care from a dedicated team of medical staff. There will be up to 14 visits to the study center.

Investigational product, examinations, and medical care relating to the study will be provided at no cost to you.

If you would like to help us in our research to develop a diabetes treatment that has the potential to be simpler and more convenient, please contact Advanced Clinical Research (ACR) at 208 377-8653, x102, x104 or x121 or complete the form below and someone will contact you.

You can also fill out our Contact Form below and we will then follow up with more information.
* Designates required fields
*Point of Interest: 
(to select multiple interest, hold down the "ctrl" key while clicking with the left mouse button)
   
*Last Name:  
   
*First Name:  
   
Middle Initial:  
   
Address Line1:  
   
Address Line2:  
   
*City:  
   
*State:  
   
Zip:  
   
*Day Time Phone:  
   
*Night Time Phone: 
   
Email Address: 
 example (jsmith@aol.com not jsmith@aol or jsmith@)
   
Best Time To Contact You:  
   
Date of Birth: 
   
Gender: FemaleMale
   
Previous Clinical Trials Participant  NoYes
   
How Did You Hear About This Study:  
   
Your Comments: